Solid Biosciences Inc’s recently made public that its Director Ganot Ilan unloaded Company’s shares for reported $1111.0 on Jan 29 ’24. In the deal valued at $7.99 per share,139 shares were sold. As a result of this transaction, Ganot Ilan now holds 8,416 shares worth roughly $76669.76.
Then, PERCEPTIVE ADVISORS LLC bought 3,410,713 shares, generating $18,861,243 in total proceeds. Upon buying the shares at $5.53, the Director now owns 6,833,539 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. bought 904,160 shares. Solid Biosciences Inc shares valued at $5,000,005 were divested by the Director at a price of $5.53 per share. As a result of the transaction, RA CAPITAL MANAGEMENT, L.P. now holds 4,192,216 shares, worth roughly $38.19 million.
William Blair initiated its Solid Biosciences Inc [SLDB] rating to an Outperform in a research note published on March 28, 2024; the price target was $40. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Piper Sandler also remained covering SLDB and has increased its forecast on March 14, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. H.C. Wainwright started covering the stock on December 08, 2023. It rated SLDB as “a Buy”.
Price Performance Review of SLDB
On Tuesday, Solid Biosciences Inc [NASDAQ:SLDB] saw its stock jump 0.77% to $9.11. Over the last five days, the stock has lost -7.23%. Solid Biosciences Inc shares have risen nearly 48.37% since the year began. Nevertheless, the stocks have risen 87.45% over the past one year. While a 52-week high of $15.05 was reached on 03/28/24, a 52-week low of $1.81 was recorded on 01/04/24. SMA at 50 days reached $10.97, while 200 days put it at $5.89. A total of 0.3 million shares were traded, compared to the trading of 0.19 million shares in the previous session.
Levels Of Support And Resistance For SLDB Stock
The 24-hour chart illustrates a support level at 8.84, which if violated will result in even more drops to 8.56. On the upside, there is a resistance level at 9.50. A further resistance level may holdings at 9.88. The Relative Strength Index (RSI) on the 14-day chart is 34.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.07%. Stochastics %K at 8.40% indicates the stock is a buying.
The most recent change occurred on July 12, 2021 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $6 price target.
